Cargando…

Lung squamous cell carcinoma and lung adenocarcinoma differential gene expression regulation through pathways of Notch, Hedgehog, Wnt, and ErbB signalling

Lung malignancies comprise lethal and aggressive tumours that remain the leading cancer-related death cause worldwide. Regarding histological classification, lung squamous cell carcinoma (LUSC) and adenocarcinoma (LUAD) account for the majority of cases. Surgical resection and various combinations o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anusewicz, Dorota, Orzechowska, Magdalena, Bednarek, Andrzej K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713208/ https://www.ncbi.nlm.nih.gov/pubmed/33273537 http://dx.doi.org/10.1038/s41598-020-77284-8

Ejemplares similares

Functional Gene Expression Differentiation of the Notch Signaling Pathway in Female Reproductive Tract Tissues—A Comprehensive Review With Analysis
por: Orzechowska, Magdalena, et al.
Publicado: (2020)

Notch Signaling Pathway in Cancer—Review with Bioinformatic Analysis
por: Anusewicz, Dorota, et al.
Publicado: (2021)

Age- and Stage-Dependent Prostate Cancer Aggressiveness Associated with Differential Notch Signaling
por: Orzechowska, Magdalena Julita, et al.
Publicado: (2022)

X or Y Cancer: An Extensive Analysis of Sex Differences in Lung Adenocarcinoma
por: Hammouz, Raneem Yaseen, et al.
Publicado: (2023)

Common profiles of Notch signaling differentiate disease-free survival in luminal type A and triple negative breast cancer
por: Orzechowska, Magdalena, et al.
Publicado: (2016)

Predictive values of Notch signalling in renal carcinoma
por: Jędroszka, Dorota, et al.
Publicado: (2017)

TGFα-EGFR pathway in breast carcinogenesis, association with WWOX expression and estrogen activation
por: Pospiech, Karolina, et al.
Publicado: (2022)

Pathway pathology: the wnt and erbB mammary tumors
por: Rosner, A, et al.
Publicado: (2001)

Differential expression of lung adenocarcinoma transcriptome with signature of tobacco exposure
por: Hammouz, Raneem Y., et al.
Publicado: (2020)

Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence
por: Pandya, K, et al.
Publicado: (2011)

Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas.
por: Rachwal, W. J., et al.
Publicado: (1995)

EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma
por: Chen, Hsuan-Yu, et al.
Publicado: (2016)

Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
por: Li, Guangyuan, et al.
Publicado: (2014)

A Novel Set of WNT Pathway Effectors as a Predictive Marker of Uterine Corpus Endometrial Carcinoma–Study Based on Weighted Co-expression Matrices
por: Kośla, Katarzyna, et al.
Publicado: (2019)

Developmental pathways associated with cancer metastasis: Notch, Wnt, and Hedgehog
por: Nwabo Kamdje, Armel Herve, et al.
Publicado: (2017)

Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4
por: Sutherland, Robert L
Publicado: (2011)

Mutational Screening in Tyrosine-Kinase Domain of erbB1 And erbB2 Genes
por: ALONSO, Juan Manuel Fernández
Publicado: (2005)

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC
por: Alvarado, Diego, et al.
Publicado: (2017)

Neuregulin-1-mediated ErbB2–ErbB3 signalling protects human trophoblasts against apoptosis to preserve differentiation
por: Fock, Valerie, et al.
Publicado: (2015)

Proliferation of Colorectal Cancer Is Promoted by Two Signaling Transduction Expression Patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK
por: Yao, Yong-Liang, et al.
Publicado: (2013)

Mammary Cells with Active Wnt Signaling Resist ErbB2-Induced Tumorigenesis
por: Bu, Wen, et al.
Publicado: (2013)

Germline ERBB3 mutation in familial non-small-cell lung carcinoma: expanding ErbB’s role in oncogenesis
por: McInerney-Leo, Aideen M, et al.
Publicado: (2021)

Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.
por: Aasland, R., et al.
Publicado: (1988)

Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
por: Wolfson, Eya, et al.
Publicado: (2018)

Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer
por: Wolfson, Eya, et al.
Publicado: (2016)

Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma
por: Chougoni, Kranthi Kumar, et al.
Publicado: (2023)

A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors
por: Meng, Y, et al.
Publicado: (2016)

Dephosphorylated parafibromin is a transcriptional coactivator of the Wnt/Hedgehog/Notch pathways
por: Kikuchi, Ippei, et al.
Publicado: (2016)

Pparγ1 Facilitates ErbB2-Mammary Adenocarcinoma in Mice
por: Jiao, Xuanmao, et al.
Publicado: (2021)

The Role of ErbB Receptors in Infection
por: Ho, Jemima, et al.
Publicado: (2017)

Combined Inhibition of ErbB1/2 and Notch Receptors Effectively Targets Breast Ductal Carcinoma In Situ (DCIS) Stem/Progenitor Cell Activity Regardless of ErbB2 Status
por: Farnie, Gillian, et al.
Publicado: (2013)

FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion
por: Benlimame, Naciba, et al.
Publicado: (2005)

ErbB1 and ErbB3 co-over expression as a prognostic factor in gastric cancer
por: Moghbeli, Meysam, et al.
Publicado: (2019)

Notch, Wnt, and Hedgehog Pathways in Rhabdomyosarcoma: From Single Pathways to an Integrated Network
por: Roma, Josep, et al.
Publicado: (2012)

DMBA promotes ErbB2-mediated carcinogenesis via ErbB2 and estrogen receptor pathway activation and genomic instability
por: Ma, Zhikun, et al.
Publicado: (2018)

Homo- and Heteroassociations Drive Activation of ErbB3
por: Váradi, Tímea, et al.
Publicado: (2019)

Inhibition of androgen-independent prostate cancer cell growth is enhanced by combination therapy targeting Hedgehog and ErbB signalling
por: Shaw, Greg, et al.
Publicado: (2008)

erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification.
por: Colomer, R., et al.
Publicado: (1994)

Betacellulin-Induced Beta Cell Proliferation and Regeneration Is Mediated by Activation of ErbB-1 and ErbB-2 Receptors
por: Oh, Yoon Sin, et al.
Publicado: (2011)

Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting
por: Singer, Josef, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tl0d2gjoe9hoaphkukp246vo9m